Opportunity Information: Apply for CDC RFA GH11 11103
Apply for CDC RFA GH11 11103
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Dominican Republic Ministry of Health in the Areas of Epidemiology, Tuberculosis, Blood Safety and Laboratory" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 31, 2011 and posted on Feb 1, 2011.
- Applicants must submit their applications by Apr 18, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $821,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This funding announcement is not a request for applications. This is a public notice of the Centers for Disease Control and Prevention s intention to fund the project activities described in the full announcement without full and open competition.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening Dominican Republic Ministry of Health in the Areas of Epidemiology, Tuberculosis, Blood Safety and Laboratory" (Funding Opportunity Number CDC RFA GH11-11103) is a Centers for Disease Control and Prevention (CDC) cooperative agreement aimed at building and improving key public health capacities within the Dominican Republic Ministry of Health. The overall purpose is straightforward: reinforce the country’s ability to prevent, detect, and respond to health threats by strengthening core systems and programs in four specific technical areas: epidemiology, tuberculosis (TB), blood safety, and laboratory services. The activity category is listed as Health, and it is tied to CFDA 93.067 (Global AIDS), which signals alignment with broader global HIV/AIDS and infectious disease priorities, even though the emphasis here is on system strengthening that supports multiple disease areas.
This opportunity is notable because it is not a standard competitive grant solicitation. The announcement explicitly states that it is not a request for applications and serves instead as a public notice of CDC’s intent to fund the described project activities without full and open competition. In practical terms, that means CDC already anticipated a specific implementing partner or a limited set of eligible entities and issued the notice to document the intended award approach rather than invite broad submissions. The eligibility category is shown as "Others (see text field entitled Additional Information on Eligibility for clarification)," which is common language in notices where eligibility is constrained or where the intended recipient is defined in the full announcement rather than the summary page.
Funding for the project was substantial for a single award. The estimated total funding amount is $2,500,000, with one expected award. The projected award size ranges from an award floor of $700,000 to an award ceiling of $821,000, suggesting a multi-year project where annual or incremental funding actions may fall within that band, while the overall project total reaches the higher aggregate figure. There is no cost-sharing or matching requirement, meaning the recipient is not required to contribute non-federal funds as a condition of the award, which can be important for ensuring activities proceed without added financial barriers.
Because the funding instrument is a cooperative agreement, CDC would be expected to have substantial involvement in the project beyond what is typical in a standard grant. Cooperative agreements are designed for situations where the federal agency anticipates ongoing programmatic collaboration, technical input, and coordination throughout implementation. In a project like this, that typically translates into close joint planning with the Ministry of Health and implementing partners, shared decisions on technical approaches, support for protocol and guideline development, assistance with monitoring and evaluation frameworks, and coordination with other CDC and international public health efforts in-country.
The four focus areas indicate a broad but interconnected strategy. Strengthening epidemiology generally means improving the ability to collect, analyze, and use health data for decision-making, including routine surveillance, outbreak investigation, and applied epidemiologic capacity such as training and field support. Tuberculosis strengthening often involves improving case detection, diagnosis, treatment monitoring, infection control practices, and program performance oversight. Blood safety work usually centers on ensuring safe blood collection, screening, storage, and transfusion practices, including quality systems that reduce the risk of transfusion-transmitted infections. Laboratory strengthening underpins all the other areas by improving diagnostic capacity, quality management systems, biosafety, specimen transport, and the reliability and timeliness of testing. Taken together, these elements typically aim to create a more resilient public health system where surveillance identifies problems quickly, laboratories confirm them accurately, clinical and public health programs respond effectively, and safety systems reduce preventable harms.
Key administrative details reflect that the opportunity was posted on February 1, 2011, with a creation date of March 31, 2011. The original closing date was April 1, 2011, later extended to April 18, 2011, and the archive date is May 18, 2011, indicating it is a historical, closed opportunity rather than an open call. For anyone trying to access the full documentation, the listing notes that the "Additional Information Link" is not active and directs users to click "Full Announcement" at the top of the page, which is typical of older grant postings. The contact point for technical access issues is the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), at 770-488-2700.
In summary, this CDC cooperative agreement was designed to strengthen essential public health infrastructure within the Dominican Republic Ministry of Health by improving epidemiologic capacity, TB program performance, blood safety systems, and laboratory services. It was structured as a single, non-competitively awarded cooperative agreement with meaningful CDC involvement, funded at up to $2.5 million total and with no matching requirement, reflecting a focused investment in foundational systems that support infectious disease control and broader health security.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Strengthening Dominican Republic Ministry of Health in the Areas of Epidemiology, Tuberculosis, Blood Safety and Laboratory" and the Funding Opportunity Number is CDC RFA GH11-11103.
Which federal agency is offering this opportunity?
This opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is used?
The funding instrument is a cooperative agreement. This generally indicates CDC expects substantial involvement in the project, including ongoing collaboration, technical input, and coordination during implementation.
What is the main purpose of the project?
The purpose is to build and improve key public health capacities within the Dominican Republic Ministry of Health by reinforcing the country’s ability to prevent, detect, and respond to health threats.
What technical areas are targeted by this cooperative agreement?
The project focuses on four areas: (1) epidemiology, (2) tuberculosis (TB), (3) blood safety, and (4) laboratory services.
How does strengthening epidemiology fit into this work?
Strengthening epidemiology typically involves improving how health data are collected, analyzed, and used for decisions. This can include routine surveillance, outbreak investigation, and applied epidemiologic capacity such as training and field support.
What kinds of activities are generally associated with tuberculosis (TB) strengthening in this project?
TB strengthening commonly includes improving case detection, diagnosis, treatment monitoring, infection control practices, and program performance oversight.
What does "blood safety" mean in the context of this opportunity?
Blood safety work generally centers on safe blood collection, screening, storage, and transfusion practices, along with quality systems intended to reduce the risk of transfusion-transmitted infections.
Why is laboratory strengthening included as a major focus area?
Laboratory systems support the other focus areas by improving diagnostic capacity, quality management systems, biosafety, specimen transport, and the reliability and timeliness of testing.
What is the activity category for this opportunity?
The activity category is Health.
What is the CFDA number associated with this opportunity, and what does it indicate?
The CFDA listing is 93.067 (Global AIDS). This signals alignment with broader global HIV/AIDS and infectious disease priorities, while the described activities emphasize strengthening systems that can support multiple disease areas.
Is this a competitive grant where organizations can submit applications?
No. The announcement explicitly states it is not a request for applications. It serves as a public notice of CDC’s intent to fund the described activities without full and open competition.
If it is not a request for applications, what does the notice represent?
It documents CDC’s intent to make an award using a non-competitive approach, typically because CDC anticipated a specific implementing partner or a limited set of eligible entities.
Who is eligible to apply?
The eligibility category is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)." This is commonly used when eligibility is constrained or when the intended recipient is defined in the full announcement rather than the summary.
How much funding is available in total?
The estimated total funding amount is $2,500,000.
How many awards does CDC expect to make?
CDC expected one award.
What are the award floor and award ceiling amounts?
The award floor is $700,000 and the award ceiling is $821,000.
Why does the opportunity show a total funding amount that is higher than the annual award range?
The summary suggests a multi-year project where annual or incremental funding actions may fall within the $700,000 to $821,000 range, while the overall project total reaches the estimated $2,500,000.
Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement, meaning the recipient is not required to contribute non-federal funds as a condition of the award.
What does CDC "substantial involvement" usually look like under a cooperative agreement?
Based on the description, CDC involvement would typically include close joint planning with the Ministry of Health and implementing partners, shared decisions on technical approaches, support for protocol and guideline development, assistance with monitoring and evaluation frameworks, and coordination with other CDC and international public health efforts in-country.
When was the opportunity posted and when did it close?
The opportunity was posted on February 1, 2011. The original closing date was April 1, 2011, later extended to April 18, 2011.
Is this opportunity currently open?
No. It is a historical, closed opportunity. The archive date is May 18, 2011.
What does the "creation date" refer to in the listing?
The listing notes a creation date of March 31, 2011, which appears as an administrative detail associated with the posting record.
Where can someone find the full announcement if the additional information link is not active?
The listing indicates the "Additional Information Link" is not active and directs users to click "Full Announcement" at the top of the page, which is typical of older grant postings.
Who should be contacted for technical access issues related to the posting?
For technical access issues, the contact is the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), at 770-488-2700.
How do the four technical areas work together as a system-strengthening approach?
Together, they are described as an interconnected strategy: surveillance and epidemiology help identify problems quickly; laboratories confirm findings accurately; TB and other programmatic responses act on that information; and blood safety and quality systems reduce preventable harms.
Which country and ministry are the intended focus of the work?
The cooperative agreement is aimed at building and improving capacities within the Dominican Republic Ministry of Health.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: FY 2011 Child Survival and Health Grants Program (CSHGP)
Previous opportunity: Improving The Dominican Republic Capacity to Plan and Conduct Monitoring and Evaluation Activities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 11103
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 11103) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY 2011 Child Survival and Health Grants Program (CSHGP) Apply for RFA OAA 11 000004 Funding Number: RFA OAA 11 000004 Agency: Agency for International Development Category: Health Funding Amount: $1,750,000 |
| Pathways for Participation Strengthening the Civil Society Response to HIV in Vietnam Project Apply for USAID VIETNAM 486 11 016 RFA Funding Number: USAID VIETNAM 486 11 016 RFA Agency: Thailand USAID Bangkok Category: Health Funding Amount: $25,000,000 |
| Genomic Research in AAT Deficiency and Sarcoidosis study (GRADS) Cooperative Research Project Grant Clinical Centers (U01) Apply for RFA HL 12 013 Funding Number: RFA HL 12 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Research in AAT Deficiency and Sarcoidosis study (GRADS) Cooperative Research Project Grant Genomics and Informatics Center (GIC) (U01) Apply for RFA HL 12 014 Funding Number: RFA HL 12 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Linkages and Care Initiative to High Risk Populations Demonstration Sites Apply for HRSA 11 098 Funding Number: HRSA 11 098 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Systems Linkages and Care Initiative to High Risk Populations Evaluation and Technical Assistance Center Apply for HRSA 11 129 Funding Number: HRSA 11 129 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Healthy Child Care America Cooperative Agreement Program Apply for HRSA 11 128 Funding Number: HRSA 11 128 Agency: Health Resources and Services Administration Category: Health Funding Amount: $375,000 |
| Support the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Central Province in the Republic of Kenya by Engaging Local Indigenous Partners under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1104 Funding Number: CDC RFA GH11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Part C CAPACITY DEVELOPMENT Apply for HRSA 11 095 Funding Number: HRSA 11 095 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository Scientific Opportunities (R21) Apply for RFA HL 12 004 Funding Number: RFA HL 12 004 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Childrens Health Insurance Program Reauthorization Act (CHIPRA) Outreach and Enrollment Grants Cycle II Apply for CMS 1Z0 11 001 Funding Number: CMS 1Z0 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $2,500,000 |
| Impact Evaluation of Combination HIV Prevention Interventions in PEPFAR Countries Apply for RFA GH 11 006 Funding Number: RFA GH 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIMHD Comprehensive Centers of Excellence (P60) Apply for RFA MD 11 003 Funding Number: RFA MD 11 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMHD Exploratory Centers of Excellence (P20) Apply for RFA MD 11 002 Funding Number: RFA MD 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV/AIDS and TB (HIV/TB) Program Component Apply for USAID SENEGAL RFA 685 11 A 11 Funding Number: USAID SENEGAL RFA 685 11 A 11 Agency: Senegal USAID Dakar Category: Health Funding Amount: $22,000,000 |
| Health System Strenghtening (HSS) Program Component Apply for USAID SENEGAL RFA 685 11 A 12 Funding Number: USAID SENEGAL RFA 685 11 A 12 Agency: Senegal USAID Dakar Category: Health Funding Amount: $20,000,000 |
| Health Services Improvement (HSI) Program Component Apply for USAID SENEGAL RFA 685 11 A 13 Funding Number: USAID SENEGAL RFA 685 11 A 13 Agency: Senegal USAID Dakar Category: Health Funding Amount: $32,000,000 |
| Strengthening the Human Resource Capacity in the Republic of Zambia to Provide Quality Care for HIV/AIDS through the Development of a Cadre of Local Experts in HIV/AIDS under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1118 Funding Number: CDC RFA GH11 1118 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The National Healthy Tomorrows Technical Assistance Resource Center Apply for HRSA 11 125 Funding Number: HRSA 11 125 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Community Health (CH) Program Component Apply for USAID SENEGAL RFA 685 11 A 14 Funding Number: USAID SENEGAL RFA 685 11 A 14 Agency: Senegal USAID Dakar Category: Health Funding Amount: $40,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 11103", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.